Caplin Point Lab

{
  "main_header": {
    "sid": 640544,
    "name": "Caplin Point Lab",
    "stock_name": "Caplin Point Lab",
    "full_name": "Caplin Point Laboratories Ltd",
    "name_url": "stocks-analysis/caplin-point-lab",
    "exchange": 1,
    "exchangecode": "",
    "primexch": 1,
    "country_id": 34,
    "currency": "INR",
    "cmp": "1,595.60",
    "chg": 9.3,
    "chgp": "0.59%",
    "dir": 1,
    "prev_price": "1,586.30",
    "mcapval": "12,342.00 Cr",
    "mcap": "Small Cap",
    "scripcode": 524742,
    "symbol": "CAPLIPOINT",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "indexname": "India SENSEX",
    "isin": "INE475E01026",
    "curr_date": "Mar 25",
    "curr_time": "",
    "bse_nse_vol": "1.17 lacs",
    "exc_status": "Active",
    "traded_date": "Mar 25, 2026",
    "traded_date_str": "2026 03 25",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/caplin-point-lab-640544-1&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0,
      "all_data": []
    }
  },
  "news": {
    "results": [
      {
        "title": "Why is Caplin Point Laboratories Ltd falling/rising?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/why-is-caplin-point-laboratories-ltd-fallingrising-3908861",
        "imagepath": "",
        "date": "2026-03-24 01:31:08",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n\n<p><strong>Recent Price Movement and Market Context</strong></p>\n<p>Caplin Point Laboratories has been under pressure in the short term, with the stock losing 4.73% over the past week and 10.01% in the last month. Year-to-date, the stock has declined by 15.32%, slightly underperforming the benchmark Sensex, which fell 14.70% in the same period. Over the last year, the stock’s performance has been particularly weak, registering a 22.64% loss compared to the Sensex’s 5.47% decline. Despite this, the company’s longer-term returns remain impressive, with gains of 158.97% over three years and 264.20% over five years, significantly outpacing the benchmark indices.</p>\n<p>On the day of the decline, the stock traded close to its 52-week low, just 0.52% above the lowest price of ₹1,551.05. Intraday, it touched ..."
      },
      {
        "title": "Caplin Point Laboratories Ltd is Rated Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/caplin-point-laboratories-ltd-is-rated-sell-3896278",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/CaplinPointLabo_mojoScore_3896278.png",
        "date": "2026-03-17 10:10:32",
        "description": "Caplin Point Laboratories Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 25 Nov 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 17 March 2026, providing investors with an up-to-date view of the company's performance and outlook."
      },
      {
        "title": "Caplin Point Laboratories Ltd is Rated Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/caplin-point-laboratories-ltd-is-rated-sell-3875590",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/CaplinPointLabo_mojoScore_3875590.png",
        "date": "2026-03-06 10:10:44",
        "description": "Caplin Point Laboratories Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 25 Nov 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 06 March 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook."
      },
      {
        "title": "Caplin Point Laboratories Ltd is Rated Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/caplin-point-laboratories-ltd-is-rated-sell-3850562",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/CaplinPointLabo_mojoScore_3850562.png",
        "date": "2026-02-23 10:10:51",
        "description": "Caplin Point Laboratories Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 25 Nov 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 23 February 2026, providing investors with an up-to-date view of the company’s performance and outlook."
      },
      {
        "title": "Caplin Point Laboratories Ltd is Rated Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/caplin-point-laboratories-ltd-is-rated-sell-3850542",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/CaplinPointLabo_mojoScore_3850542.png",
        "date": "2026-02-22 10:10:29",
        "description": "Caplin Point Laboratories Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 25 Nov 2025. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 23 February 2026, providing investors with an up-to-date view of its fundamentals, valuation, financial trends, and technical outlook."
      },
      {
        "title": "Caplin Point Laboratories Ltd is Rated Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/caplin-point-laboratories-ltd-is-rated-sell-3832619",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/CaplinPointLabo_mojoScore_3832619.png",
        "date": "2026-02-11 10:11:06",
        "description": "Caplin Point Laboratories Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 25 November 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 11 February 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trend, and technical outlook."
      },
      {
        "title": "Caplin Point Laboratories Ltd Faces Bearish Technical Shift Amid Market Volatility",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/caplin-point-laboratories-ltd-faces-bearish-technical-shift-amid-market-volatility-3827827",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/CaplinPointLabo_technicaldot_3827827.png",
        "date": "2026-02-09 08:01:24",
        "description": "Caplin Point Laboratories Ltd has experienced a notable shift in price momentum, with technical indicators signalling a bearish trend. The stock’s recent decline of 4.29% to ₹1,820.00, coupled with deteriorating moving averages and bearish MACD readings, suggests mounting pressure on the pharmaceutical firm’s near-term outlook."
      },
      {
        "title": "Caplin Point Laboratories Gains 2.70%: Mixed Signals Amid Record Quarterly Results",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/caplin-point-laboratories-gains-270-mixed-signals-amid-record-quarterly-results-3826471",
        "imagepath": "",
        "date": "2026-02-07 16:07:14",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <div class=\"highlight-box\">\n                    <h3>Key Events This Week</h3>\n                    <p><strong>2 Feb:</strong> Stock opens week at Rs.1,799.60, rising 1.23% despite Sensex decline</p>\n                    <p><strong>4 Feb:</strong> Technical momentum shift noted amid mixed market signals</p>\n                    <p><strong>5 Feb:</strong> Q3 FY26 results reveal strong profit growth but valuation concerns</p>\n                    <p><strong>6 Feb:</strong> Mixed quarterly performance reported amid margin pressure, stock dips 3.99%</p>\n                </div>\n\n                <div class=\"stats-row\">\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.1,777.75</div></div>\n                    <div class=\"stat-item\"><div class..."
      },
      {
        "title": "Caplin Point Laboratories Ltd Reports Mixed Quarterly Performance Amid Margin Pressure",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/caplin-point-laboratories-ltd-reports-mixed-quarterly-performance-amid-margin-pressure-3824597",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/CaplinPointLabo_fintrenddot_3824597.png",
        "date": "2026-02-06 16:00:18",
        "description": "Caplin Point Laboratories Ltd has reported its December 2025 quarter results, marking record highs in net sales and profitability metrics, yet facing challenges in operational efficiency and return ratios. The company’s financial trend has shifted from positive to flat, reflecting a nuanced performance that investors must carefully analyse amid a volatile pharmaceutical sector backdrop."
      }
    ],
    "total": 589,
    "sid": "640544",
    "stock_news_url": "https://www.marketsmojo.com/news/caplin-point-laboratories-640544"
  },
  "announcements": [
    {
      "details": "Caplin Point Laboratories Limited has informed the Exchange regarding a press release dated December 03, 2019, titled \"CAPLIN STERILES GETS USFDA APPROVAL FOR SODIUM NITROPRUSSIDE INJECTION\".",
      "source": "NSE",
      "caption": "Caplin Point Laboratories Limited - Press Release",
      "datetime": "03-Dec-2019"
    },
    {
      "details": "Caplin Point Laboratories Limited has informed the Exchange regarding 'Notice of Postal Ballot'.",
      "source": "NSE",
      "caption": "Caplin Point Laboratories Limited - Updates",
      "datetime": "22-Nov-2019"
    },
    {
      "details": "Caplin Point Laboratories Limited has informed the Exchange regarding Reappointment of Director of the company.",
      "source": "NSE",
      "caption": "Caplin Point Laboratories Limited - Reappointment",
      "datetime": "31-Oct-2019"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Caplin Point Laboratories Ltd has declared <strong>150%</strong> dividend, ex-date: 12 Sep 25",
          "dt": "2025-09-12",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "",
      "data": [
        {
          "txt": "Caplin Point Laboratories Ltd has announced <strong>2:10</strong> stock split, ex-date: 19 Oct 16",
          "dt": "2016-10-19",
          "middle_text": "Split"
        }
      ]
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Why is Caplin Point Laboratories Ltd falling/rising?

2026-03-24 01:31:08

Recent Price Movement and Market Context

Caplin Point Laboratories has been under pressure in the short term, with the stock losing 4.73% over the past week and 10.01% in the last month. Year-to-date, the stock has declined by 15.32%, slightly underperforming the benchmark Sensex, which fell 14.70% in the same period. Over the last year, the stock’s performance has been particularly weak, registering a 22.64% loss compared to the Sensex’s 5.47% decline. Despite this, the company’s longer-term returns remain impressive, with gains of 158.97% over three years and 264.20% over five years, significantly outpacing the benchmark indices.

On the day of the decline, the stock traded close to its 52-week low, just 0.52% above the lowest price of ₹1,551.05. Intraday, it touched ...

Read full news article

Caplin Point Laboratories Ltd is Rated Sell

2026-03-17 10:10:32

Caplin Point Laboratories Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 25 Nov 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 17 March 2026, providing investors with an up-to-date view of the company's performance and outlook.

Read full news article

Caplin Point Laboratories Ltd is Rated Sell

2026-03-06 10:10:44

Caplin Point Laboratories Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 25 Nov 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 06 March 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook.

Read full news article

Caplin Point Laboratories Ltd is Rated Sell

2026-02-23 10:10:51

Caplin Point Laboratories Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 25 Nov 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 23 February 2026, providing investors with an up-to-date view of the company’s performance and outlook.

Read full news article

Caplin Point Laboratories Ltd is Rated Sell

2026-02-22 10:10:29

Caplin Point Laboratories Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 25 Nov 2025. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 23 February 2026, providing investors with an up-to-date view of its fundamentals, valuation, financial trends, and technical outlook.

Read full news article

Caplin Point Laboratories Ltd is Rated Sell

2026-02-11 10:11:06

Caplin Point Laboratories Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 25 November 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 11 February 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trend, and technical outlook.

Read full news article

Caplin Point Laboratories Ltd Faces Bearish Technical Shift Amid Market Volatility

2026-02-09 08:01:24

Caplin Point Laboratories Ltd has experienced a notable shift in price momentum, with technical indicators signalling a bearish trend. The stock’s recent decline of 4.29% to ₹1,820.00, coupled with deteriorating moving averages and bearish MACD readings, suggests mounting pressure on the pharmaceutical firm’s near-term outlook.

Read full news article

Caplin Point Laboratories Gains 2.70%: Mixed Signals Amid Record Quarterly Results

2026-02-07 16:07:14

Key Events This Week

2 Feb: Stock opens week at Rs.1,799.60, rising 1.23% despite Sensex decline

4 Feb: Technical momentum shift noted amid mixed market signals

5 Feb: Q3 FY26 results reveal strong profit growth but valuation concerns

6 Feb: Mixed quarterly performance reported amid margin pressure, stock dips 3.99%

Week Open

Rs.1,777.75

Read full news article

Caplin Point Laboratories Ltd Reports Mixed Quarterly Performance Amid Margin Pressure

2026-02-06 16:00:18

Caplin Point Laboratories Ltd has reported its December 2025 quarter results, marking record highs in net sales and profitability metrics, yet facing challenges in operational efficiency and return ratios. The company’s financial trend has shifted from positive to flat, reflecting a nuanced performance that investors must carefully analyse amid a volatile pharmaceutical sector backdrop.

Read full news article

View All News